Oramed Pharma (ORMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 11-2010 | 09-2010 | |
| Operating Expenses | 602 | 315 |
| Operating Income | -602 | -315 |
| Interest Expense | 3 | 3 |
| Other Income | 2 | -284 |
| Pre-tax Income | -603 | -603 |
| Net Income Continuous | -603 | -603 |
| Net Income | $-603 | $-603 |
| EPS Basic Total Ops | -0.01 | N/A |
| EPS Basic Continuous Ops | -0.01 | N/A |
| EPS Diluted Total Ops | -0.01 | N/A |
| EPS Diluted Continuous Ops | -0.01 | N/A |
| EBITDA(a) | $-594 | $-315 |